US Stock MarketDetailed Quotes

IOVA Iovance Biotherapeutics

Watchlist
  • 7.380
  • +0.160+2.22%
Close Dec 20 16:00 ET
  • 7.481
  • +0.101+1.36%
Post 19:59 ET
2.25BMarket Cap-4.99P/E (TTM)

Iovance Biotherapeutics Key Stats

Iovance Biotherapeutics Q3 2024 Earnings Date

Currency:USDNov 7, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
53.82M
58.56M
+4.74M
Beat Est.
+11375.09%
+12385.07%
+8.80%
EPS
-0.30
-0.28
+0.02
Beat Est.
+35.23%
+39.13%
+6.01%
Strong Buy

Dec 12, 2024

Iovance Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 88.588M--
--2024/Q4-- / 71.570M--
Nov 7, 20242024/Q358.555M / 53.818M--
Aug 8, 20242024/Q231.106M / 24.561M--
May 9, 20242024/Q1715.000K / 2.088M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 88.588M--
--2024/Q4-- / 71.570M--
Nov 7, 20242024/Q358.555M / 53.818M--
Aug 8, 20242024/Q231.106M / 24.561M--
May 9, 20242024/Q1715.000K / 2.088M--

Unlock Free Earnings Estimates

Iovance Biotherapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Dec 12, 2024

Strong Buy

  • Buy

    88.89%
  • Hold

    11.11%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Price
% Chg

No Data